Ligne de temps
Matthieu Prot
Technicien(ne)
30 sept. 2024
publication
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies
Lire plus19 juil. 2024
publication
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2.
Lire plus13 mars 2024
publication
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.
Lire plus13 déc. 2023
01 nov. 2023
publication
Untargeted metagenomic sequencing identifies Toscana virus in patients with idiopathic meningitis, southern Spain, 2015 to 2019.
Lire plus25 oct. 2023
14 févr. 2023
publication
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.
Lire plus17 nov. 2022
publication
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.
Lire plus05 oct. 2022
publication
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.
Lire plus04 juil. 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Lire plus17 juin 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Lire plus01 juin 2022
publication
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.
Lire plus12 mars 2022
publication
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.
Lire plus01 déc. 2021
publication
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.
Lire plus01 déc. 2021
09 nov. 2021
29 sept. 2021
08 juil. 2021
24 juin 2021
11 juin 2021
publication
Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry.
Lire plus01 mai 2021
publication
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
Lire plus01 mars 2021
publication
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.
Lire plus25 sept. 2020
publication
Molecular Characterization of Dengue Type 2 Outbreak in Pacific Islands Countries and Territories, 2017-2020.
Lire plus03 sept. 2020
05 août 2020
publication
A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus.
Lire plus01 juin 2020
17 janv. 2020
publication
Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b.
Lire plus01 janv. 2020
publication
Novel genome sequences of cell-fusing agent virus allow comparison of virus phylogeny with the genetic structure of Aedes aegypti populations.
Lire plus21 juin 2019
publication
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice
Lire plus01 août 2018
publication
Corrigendum: Optic neuropathy and congenital glaucoma associated with probable Zika virus infection in Venezuelan patients.
Lire plus01 juin 2018
05 mai 2018
publication
A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival.
Lire plus01 mai 2018
publication
Optic neuropathy and congenital glaucoma associated with probable Zika virus infection in Venezuelan patients.
Lire plus19 janv. 2018
05 sept. 2017
30 août 2017
publication
Increased adaptive immune responses and proper feedback regulation protect against clinical dengue.
Lire plus13 avr. 2017
09 janv. 2017
publication
Visualization of self-delivering hydrophobically modified siRNA cellular internalization.
Lire plus01 nov. 2016
publication
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.
Lire plus10 août 2016
publication
Interferon-Induced Spermidine-Spermine Acetyltransferase and Polyamine Depletion Restrict Zika and Chikungunya Viruses.
Lire plus01 févr. 2016
publication
Control of Immune Response to Allogeneic Embryonic Stem Cells by CD3 Antibody-Mediated Operational Tolerance Induction.
Lire plus11 mai 2015
01 juin 2011
01 févr. 2011
publication
Regulation of fat specific protein 27 by isoproterenol and TNF-α to control lipolysis in murine adipocytes.
Lire plus01 janv. 2010
01 juin 2009
publication
Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy.
Lire plus01 janv. 2007
publication
Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.
Lire plus01 déc. 2006
publication
Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice.
Lire plus01 févr. 2006
15 sept. 2005
publication
A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells.
Lire plus01 juil. 2005
publication
The Lac repressor provides a reversible gene expression system in undifferentiated and differentiated embryonic stem cell.
Lire plus01 févr. 2005
publication